Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial.
BACKGROUND
Haemodialysis (HD) catheter-related blood stream infections are a major cause of morbidity and mortality in patients with acute and chronic renal failure.


METHODS
We conducted a randomized, prospective, double-blinded trial investigating the clinical value of bismuth-coated non-tunneled HD catheters in patients in need of temporary short-term vascular access. A standard catheter (SC) was compared to a surface-modified, bismuth-film-coated catheter (FCC). After removal of the catheter for any reason, both arterial and venous lumina were rinsed and the fluid cultured for detection of bacterial colony-forming units (CFU). The catheter tip was placed in a tube containing sterile saline, sonicated and shortly centrifuged to remove debris (3 min at 1000 g). The supernatant was cultured and assayed for DNA content.


RESULTS
Seventy-seven patients in three HD units were randomized. Thirteen patients suffered from acute renal failure, 60 patients from chronic renal failure, and four patients without renal insufficiency were treated with plasma exchange. The time to catheter removal was not significantly different between groups, with a mean of 18.5 +/- 2 days for SC and 15.1 +/- 2 days for FCC. In most cases, the reasons for catheter removal were related to no further need for extracorporeal therapy or establishment of a permanent vascular access. Six catheters for SC and four catheters for FCC were removed because of presumed infection. Bacterial colonization was significantly lower for coated catheters compared to standard catheters, both for cultured catheter tips as well as for CFU in rinse fluids (P < 0.05).


CONCLUSIONS
Surface modification with bismuth film reduces bacterial colonization of temporary non-tunneled HD catheters in a clinical trial. Larger trials with these modified catheters are justified to further investigate the effect on catheter-related infections, complications and costs.
Department of Nephrology and Intensive Care Medicine, Charité-Virchow-Klinikum, Universitaetsmedizin zu Berlin, Berlin, Germany. ralf.schindler@charite.de
Ralf
R
Schindler
Uwe
U
Heemann
Ulrike
U
Haug
Benjamin
B
Stoelck
Aysun
A
Karatas
Cosima
C
Pohle
Reinhold
R
Deppisch
Werner
W
Beck
Markus
M
Hollenbeck
D001424:Bacterial Infections / Q000517:prevention & control*; D001729:Bismuth; D055499:Catheter-Related Infections / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000382:microbiology*; D003114:Colony-Forming Units Assay; D004311:Double-Blind Method; D004866:Equipment Contamination; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome
D001729:Bismuth